FDA inspection
Pharmaceutical Innovations, Inc.: FDA inspection ending May 29, 2019
FDA inspection 1091030 · Official Action Indicated (OAI) · Newark, NJ
Key facts
| Inspection ID | 1091030 |
|---|---|
| Firm | Pharmaceutical Innovations, Inc. |
| FEI number | 2241583 |
| Address | 897 Frelinghuysen Ave |
| City | Newark |
| State | NJ |
| ZIP | 07114 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | May 29, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data